Combined Modality Therapy
"Combined Modality Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
Descriptor ID |
D003131
|
MeSH Number(s) |
E02.186
|
Concept/Terms |
Combined Modality Therapy- Combined Modality Therapy
- Multimodal Treatment
- Multimodal Treatments
- Treatment, Multimodal
- Treatments, Multimodal
- Therapy, Combined Modality
- Combined Modality Therapies
- Modality Therapies, Combined
- Modality Therapy, Combined
- Therapies, Combined Modality
|
Below are MeSH descriptors whose meaning is more general than "Combined Modality Therapy".
Below are MeSH descriptors whose meaning is more specific than "Combined Modality Therapy".
This graph shows the total number of publications written about "Combined Modality Therapy" by people in this website by year, and whether "Combined Modality Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1984 | 0 | 1 | 1 | 1985 | 0 | 2 | 2 | 1986 | 0 | 6 | 6 | 1987 | 0 | 4 | 4 | 1988 | 0 | 7 | 7 | 1989 | 0 | 5 | 5 | 1990 | 0 | 8 | 8 | 1991 | 0 | 5 | 5 | 1992 | 0 | 5 | 5 | 1993 | 0 | 5 | 5 | 1994 | 1 | 12 | 13 | 1995 | 0 | 9 | 9 | 1996 | 0 | 12 | 12 | 1997 | 0 | 11 | 11 | 1998 | 0 | 8 | 8 | 1999 | 0 | 8 | 8 | 2000 | 0 | 9 | 9 | 2001 | 0 | 9 | 9 | 2002 | 0 | 7 | 7 | 2003 | 2 | 25 | 27 | 2004 | 1 | 15 | 16 | 2005 | 0 | 14 | 14 | 2006 | 2 | 5 | 7 | 2007 | 0 | 3 | 3 | 2008 | 0 | 18 | 18 | 2009 | 1 | 17 | 18 | 2010 | 0 | 11 | 11 | 2011 | 0 | 17 | 17 | 2012 | 0 | 10 | 10 | 2013 | 1 | 9 | 10 | 2014 | 0 | 9 | 9 | 2015 | 1 | 17 | 18 | 2016 | 1 | 18 | 19 | 2017 | 0 | 14 | 14 | 2018 | 0 | 10 | 10 | 2019 | 1 | 11 | 12 | 2020 | 0 | 7 | 7 | 2021 | 1 | 6 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Combined Modality Therapy" by people in Profiles.
-
Walls GM, Zaidi SH, Fotiadis N, Jordan S, Maruzzo M, Hamid I, Al-Muderis O, Khabra K, Benson C, Jones RL, Judson IR, Miah AB. Treatments and Outcomes in Oligometastatic Soft Tissue Soft Sarcoma - A Single Centre Retrospective Analysis. Anticancer Res. 2021 Oct; 41(10):5089-5096.
-
Foster CC, Fleming GF, Karrison TG, Liao CY, Desai AV, Moroney JW, Ratain MJ, Nanda R, Polite BN, Hahn OM, O'Donnell PH, Vokes EE, Kindler HL, Hseu R, Janisch LA, Dai J, Hoffman MD, Weichselbaum RR, Pitroda SP, Chmura SJ, Luke JJ. Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors. Clin Cancer Res. 2021 10 15; 27(20):5510-5518.
-
Lehrich BM, Abiri A, Goshtasbi K, Birkenbeuel J, Yasaka TM, Papagiannopoulos P, Tajudeen BA, Brem EA, Kuan EC. Treatment Modalities and Survival Outcomes for Sinonasal Diffuse Large B-Cell Lymphoma. Laryngoscope. 2021 11; 131(11):E2727-E2735.
-
Talati VM, Urban MJ, Patel TR, Wojcik C, Tajudeen BA, Stenson K, Bhayani MK, Al-Khudari S, Husain IA. Laryngeal Chondrosarcoma Characteristics and Survival Analysis in the National Cancer Database. Otolaryngol Head Neck Surg. 2022 01; 166(1):101-108.
-
Li EV, Esterquest R, Pham MN, Panken EJ, Amarasekera C, Siebert A, Bajic P, Levine LA. Peyronie's disease: pharmacological treatments and limitations. Expert Rev Clin Pharmacol. 2021 Jun; 14(6):703-713.
-
Gusho CA, Blank AT, Gitelis S. Comparison of clinicopathological features and outcomes in patients with primary leiomyosarcoma of bone and soft tissue. J Surg Oncol. 2021 Apr; 123(5):1274-1283.
-
Nunna RS, Khalid SI, Patel S, Sethi A, Behbahani M, Mehta AI, Adogwa O, Byrne RW. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme. World Neurosurg. 2021 05; 149:e1026-e1037.
-
Eby M, Seder CW. Reply to "Letter to the editor of Annals of Surgical Oncology Concerning " The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer" by Sunil Kumar et al. Ann Surg Oncol. 2021 06; 28(6):3433-3434.
-
Waqar M, Rampersad S, Bennett D, Kearney T, Gnanalingham KK. Pre- and postoperative need for pituitary hormone replacement in non-adenomatous sellar and parasellar lesions: importance of the sellar encroachment score. Acta Neurochir (Wien). 2020 10; 162(10):2371-2379.
-
Farag S, Smith MJ, Fotiadis N, Constantinidou A, Jones RL. Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates Curr Treat Options Oncol. 2020 05 27; 21(7):55.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|